tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Neena Bitritto-Garg, 32 are a HOLD (21.77%), 110 are a BUY (74.83%), 5 are a SELL (3.4%).
Analyst Neena Bitritto-Garg, currently employed at DEUTSCHE BANK, carries an average stock price target met ratio of 50.65% that have a potential upside of 40.52% achieved within 209 days.
Neena Bitritto-Garg’s has documented 283 price targets and ratings displayed on 25 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on SRPT, Sarepta Therapeutics at 21-Jun-2024.
Analyst best performing recommendations are on SAGE (SAGE THERAPEUTIC).
The best stock recommendation documented was for ACAD (ACADIA PHARMACEUTICALS) at 12/12/2023. The price target of $25 was fulfilled within 1 day with a profit of $3.83 (18.09%) receiving and performance score of 180.92.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 14-Dec-2025
$33
$12.32 (59.57%)
$37
Buy Since 16-Apr-2025
$34
$13.32 (64.41%)
$36
Buy Since 25-Nov-2019
$33
$12.32 (59.57%)
$36
Buy Since 24-Sep-2025
$31
$10.32 (49.90%)
$38
Buy Since 27-Feb-2024
$35
$14.32 (69.25%)
$41
What Year was the first public recommendation made by Neena Bitritto-Garg?
